As government regulation increases to control opioid abuse, legitimate pain management practitioners are at risk for being unfairly stigmatized.
Encouraging initial findings support developing specialized clinics to manage complicated and high-risk patients on opioid therapy.
From unethical providers to doctor-shopping patients and internet pharmacies, determined individuals can obtain controlled substances in many ways.
The pros and cons of intranasal, intramuscular, and autoinjector routes of administration.
Treatment should be geared toward nerve decompression.
Understanding social mechanisms that underlie these differences can help practitioners create tailored interventions for pain in these populations.
Off-label use of commercially available cosmetic cross-linked hyaluronic acid provided relief in patients with neuropathic pain.
Drug screening is increasingly becoming part of the standard of care in pain management.